Related Experiment Videos
Sulfasalazine for alopecia areata
Charles N Ellis1, Margaret F Brown, John J Voorhees
1Department of Dermatology, 1910 A. Alfred Taubman Center, University of Michigan Medical School, Ann Arbor, MI 48109-0314, USA.
Journal of the American Academy of Dermatology
|March 22, 2002
Summary
Sulfasalazine, an immunomodulatory drug, showed potential for treating severe alopecia areata. A notable percentage of patients experienced cosmetically acceptable hair regrowth, suggesting a new therapeutic option.
Area of Science:
- Immunology
- Dermatology
- Pharmacology
Background:
- Sulfasalazine is an established therapy for autoimmune diseases like psoriasis, with presumed immunomodulatory mechanisms.
- Alopecia areata is a severe autoimmune condition impacting hair follicles.
Observation:
- Clinicians observed hair regrowth in patients with severe alopecia areata treated with sulfasalazine.
- Cosmetically acceptable hair regrowth was noted in a subset of treated patients.
Findings:
- Twenty-three percent of patients with severe alopecia areata showed a determined response to sulfasalazine treatment.
- Sulfasalazine demonstrated potential for inducing hair regrowth in severe alopecia areata.
Implications:
- Sulfasalazine's favorable safety profile supports its consideration for severe alopecia areata treatment.
- This suggests a potential new systemic therapeutic avenue for managing severe alopecia areata.